Alessandro Armuzzi

Humanitas University

Research Interests

Explore related searches

Contact this professor

Google Scholar

Articles (30)

Collaborators (20)

Henit Yanai

Armando Santoro

Humanitas University

David Drobne

Nicholas Kennedy

Honorary Clinical Senior Lecturer

University of Exeter

UNITED KINGDOM

Luis Puig

University of Barcelona

Stephen Hanauer

Professor of Medicine

Northwestern University

UNITED STATES

Flavio Caprioli

Associate professor

Università degli Studi di Torino

Triana Lobaton Ortega

Ghent University Hospital

Nick Powell

Reader in Gastroenterology

Imperial College London

UNITED KINGDOM

Byong Duk Ye

University of Ulsan College of Medicine

Ana LLEO

Professor of Internal Medicine

Humanitas University

Roberto Rusconi

Humanitas University

Valeria Cento

Associate Professor

Humanitas University

Alessandro Repici

Humanitas University

Alfredo PAPA

Professore Associato

Università Cattolica del Sacro Cuore

Axel Dignass

Goethe University Frankfurt

Antonino Spinelli

Full Professor od Surgery

Humanitas University

stefania vetrano

Assistant professor

Humanitas University

Davide Giuseppe Ribaldone

Professore associato

Edoardo Savarino

Associate Professor

University of Padua

Alessandro Armuzzi

Research Interests

Explore related searches

Contact this professor

Articles (30)

The ‘totality of evidence’ and ‘extrapolation’ of SB17, a ustekinumab biosimilar

Efficacy and Safety of Infliximab and Vedolizumab Maintenance Therapy in Patients with Crohn’s Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis

Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference

What’s new in IBD research? Refining the agenda: Outcomes, patient-centered care, and technology

Author's reply: “Enhancing the validity of histologic assessments in UC-IPAA outcomes: A critique”

Therapeutic adherence in inflammatory bowel disease: User guide from a multidisciplinary modified Delphi consensus

Navigating Neoplasm Risk in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

Adaptation of the European Crohn's Colitis Organisation quality of care standards to Italy: The Italian Group for the study of inflammatory bowel disease consensus

Collecting and Analyzing IBD Clinical Data for Machine-Learning: Insights from an Italian Cohort

TL1A as a Target in Inflammatory Bowel Disease: Exploring Mechanisms and Therapeutic Potential

The learning curve for using intestinal ultrasonography

How comparative studies can inform treatment decisions for Crohn’s disease

Transperineal Ultrasonography in the Assessment of Rectal Inflammation: Beyond the Monitoring of Ulcerative Colitis

Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: Risk Management and Surveillance Strategies

Reporting of Magnetic Resonance Enterography in Inflammatory Bowel Disease: Results of an Italian Survey

Eosinophils, Eosinophilic Gastrointestinal Diseases, and Inflammatory Bowel Disease: A Critical Review

Residual Disease Burden Among European Patients With Inflammatory Bowel Disease: A Real-World Survey

Cardiovascular Safety of Ozanimod in Patients With Ulcerative Colitis: True North and Open-Label Extension Analyses

Histologic Disease Persists beyond Mucosal Healing and Could Predict Reactivation in Ulcerative Colitis

Management of Post-Operative Crohn’s Disease: Knowns and Unknowns

Fibro-Stenosing Crohn’s Disease: What Is New and What Is Next?

Pomegranate Extract Affects Gut Biofilm Forming Bacteria and Promotes Intestinal Mucosal Healing Regulating the Crosstalk between Epithelial Cells and Intestinal Fibroblasts

Checkpoint Inhibitor-Induced Colitis: From Pathogenesis to Management.

Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn’s Disease: A Multi-Center Retrospective Cohort Study

Sarcopenia: A new route on the map for risk stratification in inflammatory bowel disease

The gasdermin protein family: emerging roles in gastrointestinal health and disease

Mental Illnesses in Inflammatory Bowel Diseases: mens sana in corpore sano

Cytokines in Spondyloarthritis and Inflammatory Bowel Diseases: From Pathogenesis to Therapeutic Implications

The role of ustekinumab and vedolizumab in management of extra intestinal manifestations in inflammatory bowel disease

Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countries

Collaborators (20)

Henit Yanai

Armando Santoro

David Drobne

Nicholas Kennedy

Luis Puig

Stephen Hanauer

Flavio Caprioli

Triana Lobaton Ortega

Nick Powell

Byong Duk Ye

Ana LLEO

Roberto Rusconi

Valeria Cento

Alessandro Repici

Alfredo PAPA

Axel Dignass

Antonino Spinelli

stefania vetrano

Davide Giuseppe Ribaldone

Edoardo Savarino

How do I reach out?

Meet Kite AI